Risk factor
Resilient to price shocks
Profitability factor
Very favourable analyst view
About
MedPlus Health Services Limited operates primarily as an Indian retailer of pharmaceutical products and diverse general merchandise. Its extensive product catalog includes vital health and wellness items such as prescription medications, vitamins, medical equipment, and diagnostic kits, alongside everyday essentials like toiletries, baby care products, cleaning supplies, and sanitizers. Beyond its retail footprint, the company also offers wholesale cash-and-carry services, comprehensive pathological laboratory testing, and contract manufacturing for its own-brand pharmaceutical goods. By March 31, 2021, MedPlus had established a substantial presence with 1,659 brick-and-mortar stores situated in the Indian states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, complemented by its online store. This Hyderabad-based company was incorporated in 2006.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on E
Target Price
The average target price of MEDPLUS.NS is 1225 and suggests 106% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to